A Phase IV, Open-Label, Randomized, Multicenter Trial Assessing a Reyataz-Based Substitution Approach in the Management of Lipodystrophy Syndrome. Research Into Atazanavir in Lipodystrophy (The REAL Study)

Trial Profile

A Phase IV, Open-Label, Randomized, Multicenter Trial Assessing a Reyataz-Based Substitution Approach in the Management of Lipodystrophy Syndrome. Research Into Atazanavir in Lipodystrophy (The REAL Study)

Completed
Phase of Trial: Phase IV

Latest Information Update: 02 Mar 2012

At a glance

  • Drugs Atazanavir; HIV protease inhibitors; Ritonavir
  • Indications HIV-1 infections; HIV-associated lipodystrophy syndrome
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms REAL
  • Sponsors Bristol-Myers Squibb
  • Most Recent Events

    • 02 Mar 2012 Results published in Antiviral Therapy.
    • 08 Oct 2008 Basic check conducted, added to study centres spreadsheet; nct last udpated 24 Sep 08.
    • 03 Aug 2008 48-week results presented at the XVII International AIDS Conference 2008.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top